The Claim
In diet-induced obese C57BL/6N mice, the combination of semaglutide and PG-110 is associated with accelerated overall weight loss compared to semaglutide alone, without significant loss of lean mass.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese mice, combining semaglutide and PG-110 leads to greater weight loss than semaglutide alone, while preserving muscle mass.
See the scientific wording
In diet-induced obese C57BL/6N mice, the combination of semaglutide and PG-110 is associated with accelerated overall weight loss compared to semaglutide alone, without significant loss of lean mass.
A drug that blocks two specific signals in the body causes fat to break down faster, while muscle stays the same size, because the body shifts energy use from storing fat to burning it, and muscle cells keep building protein instead of breaking it down.
What the research says
1 studyIn obese mice, adding a muscle-protecting drug (PG-110) to a weight-loss drug (semaglutide) helped them lose weight faster without losing muscle, just like the claim said.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.